期刊文献+

一种新的多酚化合物BJA32531抑制人肝癌HepG_2细胞的增殖和调控miRNA的表达 被引量:3

A New Natural Polyphenol BJA32531 Inhibited the Proliferation and RegulatedmiRNA Expression in Human HepG_2 Hepatocarcinoma Cells
下载PDF
导出
摘要 目的:研究从日本蛇菰中分离的天然多酚化合物1,2,6-三-O-没食子酰基-β-D-吡喃葡萄糖(BJA32531)对人肝癌细胞HepG2增殖的抑制作用以及对miRNA表达的影响。方法:采用CCK-8的方法检测HepG2细胞的增殖;用流式细胞法检测HepG2细胞的凋亡;采用miRNA芯片分析方法测定HepG2细胞的miRNA表达以及用RT-PCR的方法验证miRNA的表达。结果:BJA32531以时间和剂量依赖的方式抑制HepG2细胞的增殖;流式细胞结果表明:该化合物能引起HepG2细胞的凋亡。miRNA芯片结果显示,BJA32531能诱导HepG2细胞19个miRNA的表达上调以及85个miRNA的表达下调。RT-PCR验证了化合物诱导的let-7a和miR-10b的上调以及miR-132和miR-125b的下调与芯片的结果一致。结论:BJA32531抗HepG2细胞增殖作用的机理可能与调控miRNA的表达有关。 Objective:To study the effect of 1,2,6-Tri-O-galloyl-β-D-glucopyranose(BJA32531) on the miRNA expression during BJA32531-induced cytotoxicity in human HepG2 hepatocarcinoma cells.Methods:Cell proliferation was assessed using a colorimetric assay(cell counting kit-8).Apoptosis was assessed by annexin V and propidium iodide staining.The miRNA expression profile of the cancer cells was analyzed by a miRNA array and quantitative real-time PCR.Results: BJA32531 inhibited the cell proliferation and increased apoptosis in HepG2 cancer cells.Cellular exposure to BJA32531 influenced the miRNA expression pattern in the cells,including 19 upregulated and 85 down-regulated miRNAs in the cells.The up-regulations of let-7a and miR-10b as well as the down-regulations of miR-132 and miR-125b were verified to be consistent with the the results of the miRNA array.Conclusion: Our study suggests that the mechanisms by which BJA32531 exerted the antiproliferative effects on HepG2 cancer cells may be related to its regulation of miRNA.
出处 《中药材》 CAS CSCD 北大核心 2011年第11期1734-1740,共7页 Journal of Chinese Medicinal Materials
基金 国家自然科学基金(30901823) 广东省自然科学基金(9151051501000088) 广东高校优秀青年创新人才培育项目(LYM09039) 广东省优秀博士资助项目(sybzzxm201044)
关键词 MIRNA 人肝癌HEPG2细胞 细胞增殖 多酚化合物 BJA32531 miRNA Human HepG2 Hepatacarcinoma cells Cell proliferation Polyphend BJA32531
  • 相关文献

参考文献15

  • 1Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease [J]. DevCell,2006,11 (4) :441-450.
  • 2Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor? [J]. Cancer Metastasis Rev, 2009,28 ( 3-4 ) : 369 -378.
  • 3Calin GA, Sevignani C, Dumitru CD, et al. Human microR- NA genes are frequently located at fragile sites and genomic regions involved in cancers [ J ]. Proc Natl Acad Sci USA, 2004,101 ( 9 ) :2999-3004.
  • 4Gandellini P, Profumo V, Folini M, et al. MicroRNAs as new therapeutic targets and tools in cancer [ J]. Expert Opin Ther Targets, 2011,15 ( 3 ) : 265-279.
  • 5Nana-Sinkarm SP, Croce CM. MicroRNAs as therapeutic targets in cancer [ J]. Transl Res ,2011,157 (4) :216-225.
  • 6Jiang ZH, Hirose Y, Iwata H, et al. Caffeoyl, coumaroyl, galloyl, and hexahydroxydiphenoyl glucoses from Balano- phora japonica [ J ]. Chem Pharm Bull (Tokyo), 2001,49 (7) :887-892.
  • 7Tanaka T, Uehara R, Nishida K, et al. Galloyl, caffeoyl and hexahydroxydiphenoyl esters of dihydrochalcone glucosides from Balanophora tobiracola [ J ]. Phytochemistry , 2005,66 (6) :675-681.
  • 8孙魏,王洪涛,夏承来,吴曙光,姜世勃,姜志宏,刘叔文.三没食子酰吡喃葡糖作用于gp41抑制HIV与靶细胞的融合[J].南方医科大学学报,2008,28(7):1127-1131. 被引量:6
  • 9Wen XY, Wu SY, Li ZQ, et al. Ellagitannin ( BJA3121 ) , an anti-proliferative natural polyphenol compound, can reg- ulate the expression of MiRNAs in HepG2 cancer cells [ J ]. Phytother Res, 2009,23 ( 6 ) : 778-784.
  • 10Johnson SM, Grosshans H, Shingara J ,et al. RAS is regu- lated by the let-7 microRNA family [J]. Cell,2005,120 (5) :635-647.

二级参考文献12

  • 1刘叔文,吴曙光,姜世勃.新型抗艾滋病药物——HIV进入抑制剂的研究进展[J].中国药理学通报,2005,21(9):1034-1040. 被引量:19
  • 2Chan DC, Fass D, Berger JM, et al. Core structure of gp41 from the HIV envelope glycoprotein[J]. Cell, 1997, 89(4): 263-73.
  • 3Jiang ZH, Hirose Y, Iwata H, et al. Caffeoyl, coumaroyl, galloyl, and hexahydroxydiphenoyl glucoses from Balanophora japonica[J]. Chem Pharm Bull, 2001, 49: 887-92.
  • 4Jiang S, Lin K, Strick N, et al. HIV-1 inhibition by a peptide[J]. Nature, 1993, 365 (6442): 113.
  • 5Jiang S, Lin K, Zhang L, et al. A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody [J]. J Virol Methods, 1999, 80(1): 85-96.
  • 6Liu S, Zhao Q, Jiang S. Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV- 1 fusion inhibitors [J]. Peptides, 2003, 24(9): 1303-13.
  • 7Debnath AK, Radigan L, Jiang S. Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1[J]. J Med Chem, 1999, 42(17): 3203-9.
  • 8Liu S, Lu H, Zhao Q, et al. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41 [J]. Biochim Biophys Acta, 2005, 1723 (1-3 ): 270-81.
  • 9Au TK, Lam TL, Ng TB, et al. A comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs[J]. Life Sci, 2001, 68(14): 1687-94.
  • 10Liu S, Jiang S, Wu Z, et al. Identication ofinhibitors of the HIV-1 gp41 six-helix bundle fomation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibtte[J]. Life Sci, 2002, 71 (15): 1779-91.

共引文献5

同被引文献3

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部